A Study on the Safety and Effectiveness of Temozolomide for Neoadjuvant Treatment of PPGL
Clinical trial NCT05885386 · UNKNOWN
Trial details
- NCT number
- NCT05885386
- Sponsor
- Peking Union Medical College Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-10-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.